1- ARIA workshop report. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 ; 108 :s1476-s334.
2- Brozek JL, Bousquet J, MD, Baena-Cagnani CE, Bonini S, Canonica GW, Casale T, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines : 2010 revision. J Allergy Clin Immunol 201 ; 126(3): 466-76.
3- Braun JJ, Devillier P, Wallaert B, Rancé F, Jankowski R, Acquaviva JL, Beley G, Demoly P. Recommandations pour le diagnostic et la prise en charge de la rhinite allergique (épidémiologie et physiopathologie exclues) – Texte long. Rev Mal Resp 2010 ; 27 :s79-s105.
4- Herr M, Clarisse B, Nikasinovic L, Foucault C, Le Marec AM, Giordanella JP, Just J, Momas I. Does allergic rhinitis exist in infancy? Findings from the PARIS birth cohort. Allergy 2011; 66(2): 214-21.
5- Tan TN, Lim DL, Lee BW, Van Bever HP. Prevalence of allergy-related symptoms in Singaporean children in the second year of life. Pediatr Allergy Immunol. 2005; 16: 151-6.
6- Hardjojo A, Shek LPC, van Bever HPS, Lee BW. Rhinitis in children less than 6 years of age: current knowledge and challenges. Asia Pac allergy 2011 ; 1(3) : 115-22.
7- Brozek JL, Bousquet J, MD, Baena-Cagnani CE, Bonini S, Canonica GW, Casale T, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines : 2010 revision. J Allergy Clin Immunol 201 ; 126(3): 466-76.
8- www.allergique.org (consulté le 25 mars 2012).
9- Dutau G. Traitement de l’asthme de l’enfant et de l’adolescent. Le Généraliste 2012; 2597: 30-3.
10- Bousquet J, Lockey J, Malling HJ. Immunothérapie des allergènes : traitement vaccinal des maladies allergiques. Rev Fr Allergol Immunol Clin 1999; 39(5): 385-444
11- Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, et al. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008 ; 133 (3) : 599-609.
12- Calderon MA, Rodriguez del Rio P, Demoly P. Sulingual allergen immunotherapy in children : an évidence-based overview. Rev Fr Allergol 2012 ; 52(1) : 20-5.
13- Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006; 117(4): 802-9.
14- Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62(8): 943-8.
15- Hamelmann E, Rolinck-Werninghaus C, Wahn U, Kopp MV. Treatment with a combination of anti-IgE and specific immunotherapy for allergic rhinitis and asthma. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2009; 96: 303-13.
Étude et pratique
HTA : quelle PA cible chez les patients à haut risque cardiovasculaire ?
Mise au point
Troubles psychiatriques : quand évoquer une maladie neurodégénérative ?
Étude et pratique
Complications de FA, l’insuffisance cardiaque plus fréquente que l’AVC
Cas clinique
L’ictus amnésique idiopathique